LEXXW vs RL · rev $705.9K vs P/E 24, rev $8.11B
Lexaria Bioscience Corp (LEXXW) versus Ralph Lauren Corp Class A (RL) — a side-by-side from cached financials, not a winner call.
Lexaria Bioscience Corp (LEXXW) common stock listed on US.
Ralph Lauren Corp Class A (RL) is a apparel manufacturing company listed on US.
Latest reported LEXXW revenue for 2025-08-31 was $705.9K. Net income was -$11.9M. Revenue was up 52.0% from 2024-08-31 to 2025-08-31. LEXXW currently screens at market cap $33.8M.
Latest reported RL revenue for 2026-03-28 was $8.11B. Net income was $941.1M. Revenue was up 14.6% from 2025-03-29 to 2026-03-28. RL currently screens at market cap $16.95B and trailing P/E 24.1.
LEXXW currently screens at market cap $33.8M. RL currently screens at market cap $16.95B and trailing P/E 24.1.
Not investment advice. Open the LEXXW and RL stock pages for the full models.
Not investment advice.